$13.02
-1.27-8.89%
At close: -
$13.48
0.463.53%
After Hours: Jan 31, 7:33 PM EDT
Comments
Loading...
ARS Pharmaceuticals (NASDAQ:SPRY) Stock, Earnings Estimates, EPS, And Revenue
ARS Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 20
EPS Estimate
$-0.110
Quarterly Revenue Estimate
$17.08M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$2.57M
Analyze the earnings history of ARS Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
ARS Pharmaceuticals (SPRY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.20 | $-0.15 | -33.3 % |
| Q2 | 2024-08-06 | $-0.13 | $-0.12 | -8.33 % |
| Q1 | 2024-05-09 | $-0.11 | $-0.11 | 0.00 % |
| Q4 | 2024-03-21 | $-0.07 | $-0.14 | 50.0 % |
ARS Pharmaceuticals (SPRY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $2.07M | $560.00K | 269.3 % |
| Q2 | 2024-08-06 | $500.00K | $1.00M | -50.0 % |
FAQ
When is ARS Pharmaceuticals (NASDAQ:SPRY) reporting earnings?
ARS Pharmaceuticals (SPRY) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for ARS Pharmaceuticals (NASDAQ:SPRY)?
The Actual EPS was $-0.20, which missed the estimate of $-0.15.
What were ARS Pharmaceuticals’s (NASDAQ:SPRY) revenues?
The Actual Revenue was $2.1M, which beat the estimate of $560K.
Browse earnings estimates, EPS, and revenue on all stocks.